August 2, 2012 — Using a microneedle to inject drugs into the suprachoroidal space may provide a method for drug delivery to the posterior segment of the eye that is less invasive and more targeted ...
The current standards of care involve using anti-VEGF agents, which selectively target extracellular VEGF. We've been doing this for years and those drugs do a good job, but there are limitations ...
NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced the U.S. Centers for Medicare and Medicaid ...
A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...
Please provide your email address to receive an email when new articles are posted on . SAR446597 is designed to inhibit C1s and factor Bb in the complement pathway. Fast track designation expedites ...
Intravitreal injections of anti-VEGF were associated with a small but significant increase in the risk for stroke among patients with neovascular age-related macular degeneration. The risk was higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback